The goal of the present study was to assess whether substrate rigidity induces CTGF in GBM, whether there are differences in rigidity-mediated CTGF expression between cell lines representing different GBM subtypes and whether CTGF regulation is inversely related to monomeric actin levels in GBM. This evidence concerns the gene CCN2 and glioblastoma.